Posted on:

Is diclofenac safe during breastfeeding?

In the pharmaceutical industry, Diclofenac is a potent NSAID (Non-Steroidal Anti-Inflammatory Drug). As a pharmacist and manufacturer, I view its use during lactation as a “Second-Line Gold Standard.” While Ibuprofen is the first choice due to more extensive data, Diclofenac is considered safe and compatible with breastfeeding by major authorities like the WHO, AAP, and the NHS.

At your WHO-GMP facility in Mumbai, where you likely produce 50 mg and 100 mg tablets, understanding the pharmacokinetic “low-transfer” profile of Diclofenac is essential for your technical dossiers and B2B client support.

The “Negligible Transfer” Technical Reality

The primary reason Diclofenac is considered safe is its short half-life and high protein binding, which prevent significant amounts from entering the breast milk.

  • Relative Infant Dose (RID): The RID for Diclofenac is estimated at less than 1% (approx. 0.03 mg/kg/day). In the world of lactation pharmacology, any drug with an RID under 10% is generally considered safe for healthy, full-term infants.

  • Rapid Clearance: Diclofenac has a very short half-life (approx. 1.2 to 2 hours). This means the drug is cleared from the mother’s bloodstream—and consequently the milk—very quickly.

  • Low Bioavailability for the Infant: Even the tiny amount of Diclofenac present in milk is unlikely to be absorbed in significant quantities by the infant’s digestive system.

Clinical Recommendations (2026 Update)

Authority / Guideline Safety Status Recommendation
LactMed / AAP Compatible Considered “Acceptable” for use; unlikely to cause adverse effects.
NHS (UK) / SPS Preferred Choice Listed as a “Preferred” NSAID alongside Ibuprofen for nursing mothers.
WHO Guidelines Safe Included in the list of medicines compatible with breastfeeding.

The Pharmacist’s “Technical Strategy”

Even with a safe drug, we use three “Pharmacist’s Tactics” to minimize infant exposure:

Topical First: If the pain is localized (e.g., back pain or a sprain), suggest Diclofenac Gel. Systemic absorption from gel is negligible, making milk concentrations virtually zero.

Timing the Dose: Advise the mother to take the tablet immediately after a breastfeeding session. This allows the drug levels to peak and then fall before the next feed.

Infant Monitoring: As a precaution, the mother should watch the baby for Gastrointestinal (GI) changes, such as diarrhea or unusual fussiness, though these are extremely rare with Diclofenac.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Short-Acting” USP: On your digital marketplace, highlight that your 50 mg Immediate Release (IR) tablets are preferable for nursing mothers over the 100 mg Sustained Release (SR) versions. The IR version clears the system faster, reducing the window of infant exposure.

  • Stability for Export: Diclofenac is sensitive to moisture. For export to Zone IVb tropical regions, utilizing Alu-Alu blister packaging is mandatory to prevent degradation and ensure a 36-month shelf life.

  • Dossier Support: We provide full CTD/eCTD Dossiers with updated Lactation Safety Data to help your firm win international tenders for postpartum pain management.

Diclofenac Potassium Tablets